193 related articles for article (PubMed ID: 30078639)
1. Atypical PEX16 peroxisome biogenesis disorder with mild biochemical disruptions and long survival.
Zaabi NA; Kendi A; Al-Jasmi F; Takashima S; Shimozawa N; Al-Dirbashi OY
Brain Dev; 2019 Jan; 41(1):57-65. PubMed ID: 30078639
[TBL] [Abstract][Full Text] [Related]
2. Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case series.
Cheung A; Argyriou C; Yergeau C; D'Souza Y; Riou É; Lévesque S; Raymond G; Daba M; Rtskhiladze I; Tkemaladze T; Adang L; La Piana R; Bernard G; Braverman N
Neurogenetics; 2022 Apr; 23(2):115-127. PubMed ID: 35106698
[TBL] [Abstract][Full Text] [Related]
3. Peroxisomal assembly defects: clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group.
Poulos A; Christodoulou J; Chow CW; Goldblatt J; Paton BC; Orii T; Suzuki Y; Shimozawa N
J Pediatr; 1995 Oct; 127(4):596-9. PubMed ID: 7562283
[TBL] [Abstract][Full Text] [Related]
4. Late onset white matter disease in peroxisome biogenesis disorder.
Barth PG; Gootjes J; Bode H; Vreken P; Majoie CB; Wanders RJ
Neurology; 2001 Dec; 57(11):1949-55. PubMed ID: 11769739
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers predicting survival in peroxisome biogenesis disorders.
Gootjes J; Mooijer PA; Dekker C; Barth PG; Poll-The BT; Waterham HR; Wanders RJ
Neurology; 2002 Dec; 59(11):1746-9. PubMed ID: 12473763
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome biogenesis disorders: Biological, clinical and pathophysiological perspectives.
Braverman NE; D'Agostino MD; Maclean GE
Dev Disabil Res Rev; 2013; 17(3):187-96. PubMed ID: 23798008
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome biogenesis disorders.
Steinberg SJ; Dodt G; Raymond GV; Braverman NE; Moser AB; Moser HW
Biochim Biophys Acta; 2006 Dec; 1763(12):1733-48. PubMed ID: 17055079
[TBL] [Abstract][Full Text] [Related]
8. Drosophila carrying pex3 or pex16 mutations are models of Zellweger syndrome that reflect its symptoms associated with the absence of peroxisomes.
Nakayama M; Sato H; Okuda T; Fujisawa N; Kono N; Arai H; Suzuki E; Umeda M; Ishikawa HO; Matsuno K
PLoS One; 2011; 6(8):e22984. PubMed ID: 21826223
[TBL] [Abstract][Full Text] [Related]
9. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.
Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH
Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819
[TBL] [Abstract][Full Text] [Related]
10. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40 degrees C: implications for other inborn errors of metabolism.
Gootjes J; Schmohl F; Mooijer PA; Dekker C; Mandel H; Topcu M; Huemer M; Von Schütz M; Marquardt T; Smeitink JA; Waterham HR; Wanders RJ
Hum Mutat; 2004 Aug; 24(2):130-9. PubMed ID: 15241794
[TBL] [Abstract][Full Text] [Related]
11. Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders.
Shimozawa N; Imamura A; Zhang Z; Suzuki Y; Orii T; Tsukamoto T; Osumi T; Fujiki Y; Wanders RJ; Besley G; Kondo N
J Med Genet; 1999 Oct; 36(10):779-81. PubMed ID: 10528859
[TBL] [Abstract][Full Text] [Related]
12. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.
Chen YJ; Wang MW; Dong EL; Lin XH; Wang N; Zhang ZQ; Lin X; Chen WJ
Parkinsonism Relat Disord; 2019 Aug; 65():256-260. PubMed ID: 31227335
[TBL] [Abstract][Full Text] [Related]
13. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.
Honsho M; Tamura S; Shimozawa N; Suzuki Y; Kondo N; Fujiki Y
Am J Hum Genet; 1998 Dec; 63(6):1622-30. PubMed ID: 9837814
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomal disorders: clinical and biochemical studies in 15 children and prenatal diagnosis in 7 families.
Steinberg SJ; Elçioglu N; Slade CM; Sankaralingam A; Dennis N; Mohammed SN; Fensom AH
Am J Med Genet; 1999 Aug; 85(5):502-10. PubMed ID: 10405451
[TBL] [Abstract][Full Text] [Related]
16. A mutation in PEX19 causes a severe clinical phenotype in a patient with peroxisomal biogenesis disorder.
Mohamed S; El-Meleagy E; Nasr A; Ebberink MS; Wanders RJ; Waterham HR
Am J Med Genet A; 2010 Sep; 152A(9):2318-21. PubMed ID: 20683989
[TBL] [Abstract][Full Text] [Related]
17. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders.
Wei H; Kemp S; McGuinness MC; Moser AB; Smith KD
Ann Neurol; 2000 Mar; 47(3):286-96. PubMed ID: 10716247
[TBL] [Abstract][Full Text] [Related]
19. Severe Zellweger spectrum disorder due to a novel missense variant in the PEX13 gene: A case report and the literature review.
Su L; Peng MZ; Chen XD; Wu S; Liu L
Mol Genet Genomic Med; 2024 Jan; 12(1):e2315. PubMed ID: 37962062
[TBL] [Abstract][Full Text] [Related]
20. Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.
Zhu Z; Genchev GZ; Wang Y; Ji W; Zhang X; Lu H; Sriswasdi S; Tian G
Orphanet J Rare Dis; 2023 May; 18(1):102. PubMed ID: 37189159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
